Five companies have accepted Illumina’s self-imposed antitrust remedy and signed agreements ensuring they have access to Illumina's sequencing products and support services, among other items, following the company's merger with Grail.Illumina said Tuesday that the five companies signed “agreements with the open offer terms or substantially similar terms” they made to existing